Results were achieved in a second study, 42 days after the first dose. 11/24/2020 7:35 AM
Clarín.com
World
Updated 11/24/2020 7:35 AM
The Russian Sputnik V vaccine showed 42 days after the first dose an efficacy of more than 95%, the Gamaleya Center and the Russian Direct Investment Fund (FIDR) reported on Tuesday in a statement.
According to preliminary data from the second analysis, the efficacy of the Russian vaccine after 28 days is 91.4%.
News in development
11/24/2020 7:35 AM
Updated 11/24/2020 7:35 AM
The Russian Sputnik V vaccine showed 42 days after the first dose an efficacy of more than 95%, the Gamaleya Center and the Russian Direct Investment Fund (FIDR) reported on Tuesday in a statement.
According to preliminary data from the second analysis, the efficacy of the Russian vaccine after 28 days is 91.4%.
News in development.
JPE